We found a higher, albeit non-significant, percentage of contradiction among anti-TPO+ PV subjects (n=20) across all cutoffs compared to all anti-TPO- subjects (n=101) and the entire active PV study population (n=159) (Figure 4A). The gene discussed is TPO; the disease is acquired polycythemia vera.